Navigating through blood vessels during interventional radiology procedures is no easy task. But Toshiba American Medical Systems, Inc. hopes to make it easier with its Volume Navigation 3-D roadmapping software for the InfinixTM-i vascular X-ray product line. The system was on display this week at the Society of Interventional Radiology’s (SIR) annual meeting in Chicago.
Navigating through blood vessels during interventional radiology procedures is no easy task. But Toshiba American Medical Systems, Inc. hopes to make it easier with its Volume Navigation 3-D roadmapping software for the InfinixTM-i vascular X-ray product line. The system was on display this week at the Society of Interventional Radiology’s (SIR) annual meeting in Chicago.
The system uses a real-time road map, and can show the deployment of coils during a cerebral aneurysm procedure. The software matches up the system component’s movements with a fused 3-D and fluoroscopic display. Users can choose 2-D or 3-D displays (or each on a different monitor), and can they can control or fine tune the images with manual controls. The system is good for imaging intricate vascular areas, such as the brain, uterus and abdominal region.
“Volume Navigation provides physicians greater confidence when deciphering and navigating complex vascular structures, enabling them to perform complicated interventions more quickly and accurately,” Doug Ryan, vice president of marketing and strategic development of Toshiba, said in a statement.
The Volume Navigation system received 510(k) clearance last September and can be added on to all Toshiba Infinix-i vascular X-ray systems. Currently the system is installed at Western Medical Center in Santa Ana, Calif.
Toshiba’s product is similar to others on the market. GE Healthcare introduced Innova Vision and Innova TrackVision, for use on its Innova 4100 IQ X-ray imaging system in 2009. It also uses fluoroscopy and provides 3-D renderings, roadmapping, navigation and image-guided intervention. The system allows users to overlay a 3-D rotational X-ray, MR, or CT image with 2-D fluoroscopic image to help users advance guide wires, coils, catheters, and other devices with real-time images. They also offer a Subtracted 3-D program to visualize the vessels, removing unwanted structures to more clearly view the anatomy of interest, according to Paul Brooks, commercial marketing manager for interventional radiology at GE Healthcare.
Other companies offering a 3-D roadmapping system include Philips, with its Dynamic 3-D Roadmap.
New Study Examines Short-Term Consistency of Large Language Models in Radiology
November 22nd 2024While GPT-4 demonstrated higher overall accuracy than other large language models in answering ACR Diagnostic in Training Exam multiple-choice questions, researchers noted an eight percent decrease in GPT-4’s accuracy rate from the first month to the third month of the study.
FDA Grants Expanded 510(k) Clearance for Xenoview 3T MRI Chest Coil in GE HealthCare MRI Platforms
November 21st 2024Utilized in conjunction with hyperpolarized Xenon-129 for the assessment of lung ventilation, the chest coil can now be employed in the Signa Premier and Discovery MR750 3T MRI systems.
FDA Clears AI-Powered Ultrasound Software for Cardiac Amyloidosis Detection
November 20th 2024The AI-enabled EchoGo® Amyloidosis software for echocardiography has reportedly demonstrated an 84.5 percent sensitivity rate for diagnosing cardiac amyloidosis in heart failure patients 65 years of age and older.
New Study Examines Short-Term Consistency of Large Language Models in Radiology
November 22nd 2024While GPT-4 demonstrated higher overall accuracy than other large language models in answering ACR Diagnostic in Training Exam multiple-choice questions, researchers noted an eight percent decrease in GPT-4’s accuracy rate from the first month to the third month of the study.
FDA Grants Expanded 510(k) Clearance for Xenoview 3T MRI Chest Coil in GE HealthCare MRI Platforms
November 21st 2024Utilized in conjunction with hyperpolarized Xenon-129 for the assessment of lung ventilation, the chest coil can now be employed in the Signa Premier and Discovery MR750 3T MRI systems.
FDA Clears AI-Powered Ultrasound Software for Cardiac Amyloidosis Detection
November 20th 2024The AI-enabled EchoGo® Amyloidosis software for echocardiography has reportedly demonstrated an 84.5 percent sensitivity rate for diagnosing cardiac amyloidosis in heart failure patients 65 years of age and older.
2 Commerce Drive
Cranbury, NJ 08512